Chemical Structure : Galcanezumab
CAS No.: 1578199-75-3
货号: PC-Ab1048Not For Human Use, Lab Use Only.
Galcanezumab (LY2951742) is a humanized monoclonal antibody that selectively binds to and blocks the physiologic activity of CGRP. The FDA approved galcanezumab as a once-monthly subcutaneous injection for the preventive treatment of migraine in adults..
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Galcanezumab (LY2951742) is a humanized monoclonal antibody that selectively binds to and blocks the physiologic activity of CGRP. The FDA approved galcanezumab as a once-monthly subcutaneous injection for the preventive treatment of migraine in adults.
| 分子量 | ||
| 分子式 | Human IgG4P LALA-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Galcanezumab; Emgality; galcanezumab-gnlm; LY 2951742; LY2951742; calcitonin gene–related peptide; anti-CGRP.  | 
                    |
1. 1, Detke HC, et al. Neurology. 2018 Dec 11;91(24):e2211-e2221. 2, Gklinos P, et al. Ther Adv Neurol Disord. 2020 Apr 28;13:1756286420918088. 3, Goadsby PJ, et al. N Engl J Med. 2019 Jul 11;381(2):132-141. 4, Martin V, et al. Adv Ther. 2020 May;37(5):2034-2049.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright